Independent reporting on medical imaging.
Radiology Signal covers the clinical, business, and technology stories that shape how imaging is practiced, written for the people who actually do the work.
Our mission
Imaging sits at the intersection of clinical medicine, fast-moving technology, and a complicated business. The field deserves reporting that takes all three seriously at once. We built Radiology Signal to provide it.
The pace of change is the reason. The FDA has authorized 1,104 AI-enabled radiology devices to date, with radiology accounting for roughly 76 percent of all AI medical device clearances the agency tracks. Photon-counting CT has moved from technical curiosity to clinical adoption across cardiovascular, neuro, musculoskeletal, and oncologic imaging in under four years. Reimbursement, workforce, and policy decisions are reshaping practice at the same time. Most of this is happening faster than it is being covered.
Who we write for
Practicing radiologists, residents and fellows, imaging informatics teams, practice administrators, healthcare executives, vendors, investors, and the regulators and policy makers whose decisions shape day-to-day practice. We write for an audience that knows the field, and we assume our readers' intelligence.
What we cover, and what we don't
We cover clinical research that changes practice, the AI and informatics tools that are actually being deployed, the M&A and policy decisions that move the industry, and the operational realities of running imaging. We do not do press-release rewrites. We do not cover stories we do not think matter.
How we're funded
Clearly-labeled advertising and sponsorship. We do not accept payment in exchange for editorial coverage. See our editorial standards for the full picture.
Get in touch
Tips and feedback: contact@radiologysignal.com
Corrections: corrections@radiologysignal.com
Pitches from contributors: write@radiologysignal.com